Literature DB >> 18073301

Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men.

Nelly Pitteloud1, Andrew A Dwyer, Suzzunne DeCruz, Hang Lee, Paul A Boepple, William F Crowley, Frances J Hayes.   

Abstract

CONTEXT: Studies on the regulation of LH secretion by sex steroids in men are conflicting.
OBJECTIVE: Our aims were to determine the relative contributions of testosterone (T) and estradiol (E2) to LH regulation and localize their sites of negative feedback.
DESIGN: This was a prospective study with three arms.
SETTING: The study was conducted at a General Clinical Research Center. PATIENTS OR OTHER PARTICIPANTS: Twenty-two normal (NL) men and 11 men with GnRH deficiency due to idiopathic hypogonadotropic hypogonadism (IHH) participated. INTERVENTION: Medical castration and inhibition of aromatase were achieved using high-dose ketoconazole (KC) for 7 d with 1) no sex steroid add-back; 2) T enanthate 125 mg im starting on d 4; or 3) E2 patch 37.5 microg/d starting on d 4. Blood sampling was performed every 10 min for 12 h at baseline, overnight on d 3-4 and d 6-7. MAIN OUTCOME MEASURES: Mean LH levels, LH pulse amplitude, and GnRH pulse frequency were assessed at baseline, d 3-4, and d 6-7.
RESULTS: In NL men, KC caused a 3-fold increase in mean LH on d 3-4, which was stable on d 6-7 with no add-back. Addition of T reduced LH levels (34.6+/-3.9 to 17.4+/-3.6 IU/liter, P<0.05) by slowing GnRH pulse frequency (13.3+/-0.4 to 6.7+/-1.0 pulses/12 h, P<0.005). LH amplitude increased (6.9+/-1.0 to 12.1+/-1.4 IU/liter, P<0.005). E2 add-back suppressed LH levels (36.4+/-5.6 to 19.0+/-2.4 IU/liter, P<0.005), by slowing GnRH pulse frequency (11.4+/-0.2 to 8.6+/-0.4 pulses/12 h, P<0.05) and had no impact on LH pulse amplitude. In IHH men, restoring normal T levels caused no suppression of mean LH levels or LH amplitude. E2 add-back normalized mean LH levels and decreased LH amplitude from 14.7+/-1.7 to 12+/-1.5 IU/liter (P<0.05).
CONCLUSIONS: 1) T and E2 have independent effects on LH. 2) Inhibition of LH by T requires aromatization for its pituitary, but not hypothalamic effects. 3) E2 negative feedback on LH occurs at the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18073301      PMCID: PMC2266963          DOI: 10.1210/jc.2007-2156

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  32 in total

1.  Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback.

Authors:  F J Hayes; S B Seminara; S Decruz; P A Boepple; W F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

2.  Studies on the role of sex steroids in the feedback control of gonadotropin concentrations in men. II. Use of the estrogen antagonist, clomiphene citrate.

Authors:  S J Winters; J J Janick; D L Loriaux; R J Sherins
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

3.  Enhanced frequency and magnitude of episodic luteinizing hormone-releasing hormone discharge as a hypothalamic mechanism for increased luteinizing hormone secretion.

Authors:  R J Santen; E B Ruby
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

4.  The effect of clomiphene citrate on the 24-hour LH secretory pattern in normal men.

Authors:  R M Boyar; M Perlow; S Kapen; G Lefkowitz; E Weitzman; L Hellman
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

5.  Is aromatization of testosterone to estradiol required for inhibition of luteinizing hormone secretion in men?

Authors:  R J Santen
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

6.  Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback.

Authors:  Vincenzo Rochira; Lucia Zirilli; Alessandro D Genazzani; Antonio Balestrieri; Claudio Aranda; Bibiana Fabre; Paula Antunez; Chiara Diazzi; Cesare Carani; Laura Maffei
Journal:  Eur J Endocrinol       Date:  2006-10       Impact factor: 6.664

7.  Aromatization mediates testosterone's short-term feedback restraint of 24-hour endogenously driven and acute exogenous gonadotropin-releasing hormone-stimulated luteinizing hormone and follicle-stimulating hormone secretion in young men.

Authors:  J A Schnorr; M J Bray; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

8.  Importance of inhibin B in the regulation of FSH secretion in the human male.

Authors:  F J Hayes; N Pitteloud; S DeCruz; W F Crowley; P A Boepple
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

9.  Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms.

Authors:  R J Santen; C W Bardin
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

10.  The antiandrogenic effects of delta 1-testolactone (Teslac) in vivo in rats and in vitro in human cultured fibroblasts, rat mammary carcinoma cells, and rat prostate cytosol.

Authors:  R A Vigersky; D Mozingo; C Eil; V Purohit; J Bruton
Journal:  Endocrinology       Date:  1982-01       Impact factor: 4.736

View more
  29 in total

1.  Potential diagnostic utility of intermittent administration of short-acting gonadotropin-releasing hormone agonist in gonadotropin deficiency.

Authors:  Carrie A Zimmer; David A Ehrmann; Robert L Rosenfield
Journal:  Fertil Steril       Date:  2010-05-31       Impact factor: 7.329

2.  GPRC6A mediates the non-genomic effects of steroids.

Authors:  Min Pi; Abby L Parrill; L Darryl Quarles
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

3.  Functional Hypogonadotropic Hypogonadism in Men: Underlying Neuroendocrine Mechanisms and Natural History.

Authors:  Andrew A Dwyer; Niraj R Chavan; Hilana Lewkowitz-Shpuntoff; Lacey Plummer; Frances J Hayes; Stephanie B Seminara; William F Crowley; Nelly Pitteloud; Ravikumar Balasubramanian
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

Review 4.  Hypogonadism and metabolic syndrome.

Authors:  G Corona; G Rastrelli; A Morelli; L Vignozzi; E Mannucci; M Maggi
Journal:  J Endocrinol Invest       Date:  2011-06-27       Impact factor: 4.256

Review 5.  Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity.

Authors:  Robert L Rosenfield; Brian Bordini
Journal:  Brain Res       Date:  2010-09-25       Impact factor: 3.252

Review 6.  Tissue physiology and pathology of aromatase.

Authors:  Carlos Stocco
Journal:  Steroids       Date:  2011-11-13       Impact factor: 2.668

Review 7.  Aromatase deficiency in men: a clinical perspective.

Authors:  Vincenzo Rochira; Cesare Carani
Journal:  Nat Rev Endocrinol       Date:  2009-08-25       Impact factor: 43.330

Review 8.  Brain aromatization: classic roles and new perspectives.

Authors:  Charles E Roselli; Mingyue Liu; Patricia D Hurn
Journal:  Semin Reprod Med       Date:  2009-04-28       Impact factor: 1.303

9.  The relative role of gonadal sex steroids and gonadotropin-releasing hormone pulse frequency in the regulation of follicle-stimulating hormone secretion in men.

Authors:  Nelly Pitteloud; Andrew A Dwyer; Suzzunne DeCruz; Hang Lee; Paul A Boepple; William F Crowley; Frances J Hayes
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

Review 10.  Testosterone deficiency, insulin resistance and the metabolic syndrome.

Authors:  Michael Zitzmann
Journal:  Nat Rev Endocrinol       Date:  2009-10-27       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.